About Index Trending news
Analyze
Top 50 Pricing
Delinia

Delinia

Work at Delinia? Add yourself to this profile

Delinia

Delinia aims to discover and develop novel therapeutics targeting regulatory T cells for the treatment of autoimmune and inflammatory diseases

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$35,000,000
Employees

Unknown size

Locations
HQ
$35,000,000 Venture capital (Series A)
businesswire , FinSMEs

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases | Business Wire